The requested information is provided in Portable Document Format (PDF). To view and print this document you'll need to install a copy of the free Adobe® Acrobat® Reader®. If you already have Adobe Acrobat Reader installed click "View PDF" below. If you need the Acrobat Reader you can download it from the Adobe Acrobat Reader Download page.

 

You are leaving Suboxone.com. Links are provided as a public service and for informational purposes only. No endorsement is made or implied. Clicking on "Continue" will take you to a website that is outside the control of Reckitt Benckiser Pharmaceuticals. You are solely responsible for your interactions with such websites.

 

Links are provided as a public service and for informational purposes only.

 

On December 8, 2006, Federal legislation was passed allowing physicians to treat up to 100 opioid dependent patients with Suboxone at any given time—a significant increase from the previous limit of 30 patients.

 

Dear "Your Doctor's Name"

A patient in your practice is interested in receiving office-based treatment for opioid dependence and would like to encourage you to become a certified SUBOXONE® prescriber.

Opioid dependence is a chronic medical condition. In 2003, an estimated 2.4 million people in the United States were dependent on or abusing opioid analgesics and/or heroin. The stigma attached to opioid dependence can be so overwhelming that thousands of patients every year choose to continue using rather than risk possible exposure by receiving treatment.

Because SUBOXONE is approved for office-based treatment of opioid dependence, it allows for privacy and confidentiality in the treatment of this disease. SUBOXONE suppresses withdrawal symptoms, decreases cravings, and improves treatment retention.

According to the DATA 2000, if you meet any of the following criteria, you are considered prequalified to prescribe SUBOXONE for opioid dependence:

• Subspecialty board certified in addiction psychiatry from the American Board of Medical Specialties
• Addiction certification from the American Society of Addiction Medicine
• Subspecialty board certified in addiction medicine from the American Osteopathic Association
• Participated as an investigator in 1 or more clinical trials leading to the approval of SUBOXONE

Physicians can become qualified to prescribe SUBOXONE by participating in an 8-hour, DATA 2000—approved training course. Information about upcoming training sessions and registration is available at www.DocOptIn.com and www.bupenorphine.samhsa.gov, or by calling 1-888-DOC-OPTIN (1-888-362-6784).

All physicians must submit a Notification of Intent to treat form (SMA 167) to the Substance Abuse and Mental Health Services Administration (SAMHSA) for processing before they are legally recognized as DATA 2000 certified. Additional information about training and other aspects of becoming certified is found at Suboxone.com under Frequently Asked Questions.

Thank you for considering offering opioid-dependence treatment and SUBOXONE to your opioid-dependent patients. Today, someone in your practice looks forward to beginning office-based treatment with your professional assistance.

Sincerely,

Rolley E. Johnson, Pharm.D.
VP of Clinical, Scientific and Regulatory Affairs
Reckitt Benckiser Pharmaceuticals, Inc.